JP2014508749A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014508749A5 JP2014508749A5 JP2013553642A JP2013553642A JP2014508749A5 JP 2014508749 A5 JP2014508749 A5 JP 2014508749A5 JP 2013553642 A JP2013553642 A JP 2013553642A JP 2013553642 A JP2013553642 A JP 2013553642A JP 2014508749 A5 JP2014508749 A5 JP 2014508749A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- less
- characters
- months
- inner tube
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161442151P | 2011-02-11 | 2011-02-11 | |
| US61/442,151 | 2011-02-11 | ||
| PCT/US2012/024910 WO2012109673A1 (en) | 2011-02-11 | 2012-02-13 | Methods of treating macular edema using antiedema therapeutics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014508749A JP2014508749A (ja) | 2014-04-10 |
| JP2014508749A5 true JP2014508749A5 (https=) | 2015-02-12 |
Family
ID=46637026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013553642A Pending JP2014508749A (ja) | 2011-02-11 | 2012-02-13 | 抗浮腫治療薬を使用する黄斑浮腫の治療方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20120207682A1 (https=) |
| EP (1) | EP2673049A4 (https=) |
| JP (1) | JP2014508749A (https=) |
| CN (1) | CN103402582A (https=) |
| AU (1) | AU2012214146A1 (https=) |
| CA (1) | CA2827082A1 (https=) |
| RU (1) | RU2013138180A (https=) |
| WO (1) | WO2012109673A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010129545A2 (en) | 2009-05-04 | 2010-11-11 | Psivida Us, Inc. | Porous silicon drug-eluting particles |
| EP2635255B1 (en) | 2010-11-01 | 2019-08-21 | EyePoint Pharmaceuticals US, Inc. | Bioerodible silicon-based devices for delivery of therapeutic agents |
| WO2013056240A1 (en) | 2011-10-13 | 2013-04-18 | Aerpio Therapeutics, Inc. | Methods for treating vascular leak syndrome and cancer |
| EP2968882B1 (en) * | 2013-03-12 | 2021-05-19 | EyePoint Pharmaceuticals US, Inc. | Drug delivery device comprising silicon-based carrier particles |
| TR201808197T4 (tr) * | 2013-03-14 | 2018-07-23 | Eyecro Llc | Mikroemülsiyon topikal dağıtım platformu. |
| US20150050277A1 (en) | 2013-03-15 | 2015-02-19 | Aerpio Therapeutics Inc. | Compositions and methods for treating ocular diseases |
| AU2014233363B2 (en) * | 2013-03-15 | 2017-06-29 | EyePoint, Inc. | Compositions, formulations and methods for treating ocular diseases |
| EP2968571A4 (en) | 2013-03-15 | 2016-09-07 | Psivida Inc | BIODEGRADABLE SILICONE BASED COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC AGENTS |
| SG10201809363SA (en) * | 2013-11-15 | 2018-11-29 | Allergan Inc | Methods of treatment of ocular conditions with a sustained drug delivery implant |
| BR112019001206A2 (pt) | 2016-07-20 | 2019-06-25 | Aerpio Therapeutics Inc | anticorpos monoclonais humanizados que visam ve-ptp (hptp-ss) |
| EP4537830A3 (en) | 2017-06-13 | 2025-06-11 | EyePoint Pharmaceuticals, Inc. | Bioerodible drug delivery devices |
| EP3803866A4 (en) | 2018-05-24 | 2022-03-16 | Nureva Inc. | METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS |
| MX2020012459A (es) | 2018-05-24 | 2021-04-28 | Celanese Eva Performance Polymers Llc | Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular. |
| KR20260007295A (ko) | 2018-05-24 | 2026-01-13 | 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 | 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치 |
| BR112023022439A2 (pt) | 2021-04-26 | 2023-12-26 | Celanese Eva Performance Polymers Llc | Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6375972B1 (en) * | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| US8871241B2 (en) * | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
| NZ575950A (en) * | 2003-11-13 | 2010-06-25 | Psivida Inc | Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin |
| US9173773B2 (en) * | 2006-06-21 | 2015-11-03 | Johnson & Johnson Vision Care, Inc. | Punctal plugs for the delivery of active agents |
| US20080153819A1 (en) * | 2006-12-21 | 2008-06-26 | Bingaman David P | Methods for treating macular edema and pathologic ocular angiogenesis using a neuroprotective agent and a receptor tyrosine kinase inhibitor |
| KR20160021307A (ko) * | 2007-07-10 | 2016-02-24 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 선택된 조직에 조성물을 전달하는 물질 및 방법 |
| WO2010129545A2 (en) * | 2009-05-04 | 2010-11-11 | Psivida Us, Inc. | Porous silicon drug-eluting particles |
-
2012
- 2012-02-13 JP JP2013553642A patent/JP2014508749A/ja active Pending
- 2012-02-13 RU RU2013138180/15A patent/RU2013138180A/ru not_active Application Discontinuation
- 2012-02-13 WO PCT/US2012/024910 patent/WO2012109673A1/en not_active Ceased
- 2012-02-13 CA CA2827082A patent/CA2827082A1/en not_active Abandoned
- 2012-02-13 EP EP12744598.9A patent/EP2673049A4/en not_active Withdrawn
- 2012-02-13 CN CN2012800110513A patent/CN103402582A/zh active Pending
- 2012-02-13 AU AU2012214146A patent/AU2012214146A1/en not_active Abandoned
- 2012-02-13 US US13/372,302 patent/US20120207682A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014508749A5 (https=) | ||
| RU2013138180A (ru) | Способы лечения макулярного отека с использованием противоотечных лекарственных средств | |
| Chang-Lin et al. | Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant | |
| Boyer et al. | Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema | |
| Herrero-Vanrell et al. | Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema | |
| US9216106B2 (en) | Device and method for the delivery of drugs for the treatment of posterior segment disease | |
| JP5455624B2 (ja) | 後眼部の疾患治療用のステロイドプロドラッグの使用 | |
| Nguyen et al. | Intravitreal sirolimus for the treatment of noninfectious uveitis: evolution through preclinical and clinical studies | |
| JP2008500282A (ja) | 眼症状の治療 | |
| EP2958579A1 (en) | Oral steroid formulations for use in the treatment of intestinal fibrosis | |
| CN103705524A (zh) | 具有二氟泼尼酯的黄斑水肿治疗用滴眼剂 | |
| Gupta et al. | Intraoperative dexamethasone implant in uveitis patients with cataract undergoing phacoemulsification | |
| Gruszka | Potential involvement of mineralocorticoid receptor activation in the pathogenesis of central serous chorioretinopathy: case report | |
| Larochelle et al. | Dexamethasone intravitreal implant in the treatment of uveitic macular edema in the perioperative cataract setting: a case series | |
| CN101678034A (zh) | 治疗新血管眼病的方法 | |
| Ryder et al. | Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion | |
| Amer et al. | Review on the use of difluprednate in inflammatory eye disorders: the topical steroid that goes the distance | |
| CN100431544C (zh) | 用于治疗病理性眼血管生成的糖皮质激素制剂 | |
| JP2016138116A (ja) | 網膜中および／または網膜下における液体貯留の処置のための方法および組成物 | |
| US20240366632A1 (en) | Methods for the treatment of ocular rosacea | |
| Annadanam et al. | Dropless cataract surgery | |
| Kiss | Sustained-release corticosteroid delivery systems | |
| Sejpal et al. | Surgical intervention of steroid-induced ocular hypertension from Ozurdex | |
| de Zea et al. | Dexamethasone intravitreal implant for treatment of persistent macular oedema in Birdshot retinochoroidopathy | |
| Sharma et al. | Use of Intravitreal triamcinolone in the treatment of macular edema related to retinal vein occlusion |